21.
Impact of Local Administration of Liposome Bupivacaine for Postsurgical Analgesia on Wound Healing: A Review of Data From Ten Prospective, Controlled Clinical Studies
by Baxter, Richard, MD
Clinical therapeutics, 2013, Vol.35 (3), p.312-320.e5

22.
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
by Seymour, Matthew T, Prof
The Lancet (British edition), 2011, Vol.377 (9779), p.1749-1759

23.
SARS-CoV-2 infection of the oral cavity and saliva
by Huang, Ni
Nature medicine, 2021-05, Vol.27 (5), p.892-903

24.
Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data
by Wright, Caroline F, Dr
The Lancet (British edition), 2015, Vol.385 (9975), p.1305-1314

25.
Host feeding patterns of established and potential mosquito vectors of West Nile virus in the eastern United States
by Apperson, Charles S
Vector borne and zoonotic diseases (Larchmont, N.Y.), 2004, Vol.4 (1), p.71-82

26.
Surgery for Graves’ disease: a 25-year perspective
by Phitayakorn, Roy, M.D., M.H.P.E
The American journal of surgery, 2013, Vol.206 (5), p.669-673

27.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
by Lees, Kennedy R, Prof
The Lancet (British edition), 2010, Vol.375 (9727), p.1695-1703

28.
The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome
by Baer, Alan N
Annals of the rheumatic diseases, 2015-08, Vol.74 (8), p.1557-1561

29.
Pathogenic Variants for Mendelian and Complex Traits in Exomes of 6,517 European and African Americans: Implications for the Return of Incidental Results
by Tabor, Holly K
American journal of human genetics, 2014-08-07, Vol.95 (2), p.183-193

30.
Changes in Eating Behaviors of Children with Obesity in Response to Carbohydrate-Modified and Portion-Controlled Diets
by Shelley Kirk
Obesity management, 2017-10-01, Vol.13 (5), p.377

31.
The Relationships of Adiponectin with Insulin and Lipids Are Strengthened with Increasing Adiposity
by Martin, Lisa J
The journal of clinical endocrinology and metabolism, 2005-07, Vol.90 (7), p.4255-4259

32.
Relation between the changes in physical activity and body-mass index during adolescence: a multicentre longitudinal study
by Kimm, Sue YS
The Lancet (British edition), 2005, Vol.366 (9482), p.301-307

33.
Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asth...
by Fitzpatrick, Anne M., PhD
Journal of allergy and clinical immunology, 2011, Vol.127 (2), p.382-389.e13

34.
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies
by Myers, Candace T
American journal of human genetics, 2016-08-04, Vol.99 (2), p.287-298

35.
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
by Raal, Frederick J, Prof
The Lancet (British edition), 2015, Vol.385 (9965), p.341-350

36.
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
by Bergenstal, Richard M, Dr
The Lancet (British edition), 2010, Vol.376 (9739), p.431-439

37.
Global Analysis of DNA Methylation Variation in Adipose Tissue from Twins Reveals Links to Disease-Associated Variants in Distal Regulatory Elements
by Grundberg, Elin
American journal of human genetics, 2013-11-07, Vol.93 (5), p.876-890

38.
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disea...
by Arora, Megha
The Lancet (British edition), 2016, Vol.388 (10053), p.1545-1602

39.
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-c...
by Smolen, Josef S, Prof
The Lancet (British edition), 2009, Vol.374 (9685), p.210-221

40.
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Glo...
by Arora, Megha
The Lancet (British edition), 2016, Vol.388 (10053), p.1603-1658
